Ryan Specialty Holdings, Inc. (NYSE:RYAN) Director Buys $267,404.88 in Stock

Ryan Specialty Holdings, Inc. (NYSE:RYANGet Rating) Director Michael D. Ohalleran bought 7,724 shares of Ryan Specialty stock in a transaction dated Thursday, November 17th. The shares were bought at an average cost of $34.62 per share, for a total transaction of $267,404.88. Following the completion of the acquisition, the director now owns 581,952 shares in the company, valued at approximately $20,147,178.24. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.

Ryan Specialty Price Performance

Ryan Specialty stock opened at $37.51 on Friday. The company has a current ratio of 1.27, a quick ratio of 1.27 and a debt-to-equity ratio of 2.58. The company has a market capitalization of $9.74 billion, a PE ratio of 81.54 and a beta of 0.71. Ryan Specialty Holdings, Inc. has a 12 month low of $32.13 and a 12 month high of $46.40. The stock has a 50-day moving average price of $41.13 and a two-hundred day moving average price of $40.46.

Hedge Funds Weigh In On Ryan Specialty

Several large investors have recently bought and sold shares of the company. M&T Bank Corp raised its position in Ryan Specialty by 5.3% in the third quarter. M&T Bank Corp now owns 142,891 shares of the company’s stock valued at $5,804,000 after purchasing an additional 7,209 shares during the last quarter. CIBC Private Wealth Group LLC raised its position in Ryan Specialty by 546.7% in the third quarter. CIBC Private Wealth Group LLC now owns 140,414 shares of the company’s stock valued at $5,704,000 after purchasing an additional 118,701 shares during the last quarter. Fred Alger Management LLC bought a new position in shares of Ryan Specialty during the third quarter worth about $939,000. BNP Paribas Arbitrage SNC bought a new position in shares of Ryan Specialty during the third quarter worth about $3,374,000. Finally, State Street Corp raised its position in shares of Ryan Specialty by 14.8% during the third quarter. State Street Corp now owns 1,396,030 shares of the company’s stock worth $56,707,000 after acquiring an additional 179,720 shares during the last quarter. 26.60% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several research firms have recently issued reports on RYAN. UBS Group reduced their target price on Ryan Specialty to $48.00 in a report on Wednesday. JPMorgan Chase & Co. dropped their price objective on Ryan Specialty from $40.00 to $39.00 in a research report on Friday, November 11th. Barclays dropped their price objective on Ryan Specialty to $49.00 in a research report on Wednesday. Wells Fargo & Company dropped their price objective on Ryan Specialty from $44.00 to $41.00 and set an “equal weight” rating for the company in a research report on Friday, November 11th. Finally, Royal Bank of Canada dropped their price objective on Ryan Specialty from $47.00 to $46.00 and set a “sector perform” rating for the company in a research report on Friday, November 11th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $45.00.

About Ryan Specialty

(Get Rating)

Ryan Specialty Group Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.

Read More

Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.